We have implemented a hand-held photoacoustic and ultrasound probe for image-guided needle biopsy using a modified clinical ultrasound array system. Pulsed laser light was delivered via bifurcated optical fiber bundles integrated with the hand-held ultrasound probe. We photoacoustically guided needle insertion into rat sentinel lymph nodes (SLNs) following accumulation of indocyanine green (ICG). Strong photoacoustic image contrast of the needle was achieved. After intradermal injection of ICG in the left forepaw, deeply positioned SLNs (beneath 2-cm thick chicken breast) were easily indentified in vivo and in real time. Further, we confirmed ICG uptake in axillary lymph nodes with in vivo and ex vivo fluorescence imaging. These results demonstrate the clinical potential of this hand-held photoacoustic system for facile identification and needle biopsy of SLNs for cancer staging and metastasis detection in humans.
INTRODUCTION
The surgical removal of primary breast tumor and dissection of all level I and level II axillary lymph nodes were widely performed in the treatment of invasive breast cancers. 1 However, common side effects after axillary lymph node dissection (ALND) include upper-extremity lymphedema, arm numbness, impaired shoulder mobility, arm weakness, and infections in the breast, chest, or arm. 2, 3 Therefore, as a less invasive alternative to ALND, sentinel lymph node biopsy (SLNB), that is, biopsy of the first lymph node receiving drainage from a cancer-containing area of the breast, has become increasingly important in breast cancer staging and treatment. 4 By reducing the number of lymph nodes removed, SLNB reduces the risk of side effects compared to ALND. 2 Although SLNB with methylene blue dye and radioactive tracers has an identification rate of 90-95% and a sensitivity of 88-95%, [2] [3] [4] it remains a highly invasive procedure involving ionizing radiation.
Photoacoustic (PA) imaging is a nonionizing and noninvasive hybrid imaging technique that combines strong optical absorption contrast with high ultrasonic spatial resolution. 5, 6 Since ultrasonic scattering is 2-3 orders of magnitude less than optical scattering, PA imaging can break through the fundamental depth limitations of pure optical imaging. Using intrinsic contrasts such as hemoglobin or melanin, PA imaging can provide both morphological and functional information. Moreover, using molecularly targeted exogenous contrast agents, it can also provide molecular information. imaging syst agents.
7-11 H view), and i using a US a In this proce rats using a P bundles for fluorescence insertion. The development of a real-time, noninvasive technique for identifying sentinel lymph nodes offers the possibility of percutaneous needle biopsies for axillary staging of breast cancer. Percutaneous needle biopsies would offer patients a nonsurgical option that is not currently available, likely improving patient outcomes while reducing patient morbidity. Currently, the results for SLNB performed during lumpectomy are often not known until after surgery, so for positive SLNB patients a second surgical visit to undergo ALND is required. Needle biopsies could be performed preoperatively and, in cases of positive lymph nodes, ALND can be performed at the time of lumpectomy, without needing a second surgical visit. Photoacoustic imaging has the unique capability to image both the needle and sentinel lymph nodes stained by optical dyes, which provides a strong clinical potential for this technique. Photoacoustic imaging is compatible with clinically used dyes such as ICG, as demonstrated here, and methylene blue, which is more commonly used during SLNB.
CONCLUSIONS
We have developed a noninvasive, nonionizing, real-time, and hand-held PA and US imaging system using a modified clinical US imaging system. In vivo mapping of rat SLNs at an imaging depth of ~2.1 cm was successfully accomplished following ICG injection. Further, PA imaging enabled guided needle insertion with strong contrast in a tissue mimicking phantom. This technique is highly translatable to clinical applications for image-guided SLN biopsy, nerve blockings, and many others.
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